Showing results (421-430 of 454) with videos related to

Sort By:
Pageof 46
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Radioimmunotherapy of small volume disease of colorectal cancer metastatic to the liver: preclinical evaluation in comparison to standard chemotherapy and initial results of a phase I clinical studyT M Behr, A L Salib, T Liersch, et al.
Oncogene|February 26, 2013
CD84 is a survival receptor for CLL cellsI Binsky-Ehrenreich, A Marom, M C Sobotta, et al.
The American Journal of Medicine|June 1, 1983
Therapeutic trial of cryofiltration in patients with rheumatoid arthritisR S Krakauer, A J Wysenbeek, D J Wallace, et al.
Lupus|December 6, 2012
Safety profile of belimumab: pooled data from placebo-controlled phase 2 and 3 studies in patients with systemic lupus erythematosusD J Wallace, S Navarra, M A Petri, et al.
British Journal of Cancer|July 18, 2013
Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical resultsR Schoffelen, O C Boerman, D M Goldenberg, et al.
Lupus|October 13, 2010
Depression predicts self-reported disease activity in systemic lupus erythematosusF N Carr, P M Nicassio, M L Ishimori, et al.
Lupus|May 29, 2018
Less than 7 hours of sleep per night is associated with transitioning to systemic lupus erythematosusK A Young, M E Munroe, J B Harley, et al.
The Journal of Clinical Investigation|April 20, 1999
PARP alleles within the linked chromosomal region are associated with systemic lupus erythematosusB P Tsao, R M Cantor, J M Grossman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 18, 2020
Sacituzumab govitecan in previously treated hormone receptor-positive/HER2-negative metastatic breast cancer: final results from a phase I/II, single-arm, basket trialK Kalinsky, J R Diamond, L T Vahdat, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 22, 2020
Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot studyY Touchefeu, C Bailly, E Frampas, et al.
Pageof 46